<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17</article-id><article-id pub-id-type="publisher-id">2008MOLVIS0422</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of <italic>MFRP</italic> as a candidate gene for high hyperopia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Panfeng</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Zhikuan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Shiqiang</given-names></name></contrib><contrib contrib-type="author"><name><surname>Xiao</surname><given-names>Xueshan</given-names></name></contrib><contrib contrib-type="author"><name><surname>Guo</surname><given-names>Xiangming</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhang</surname><given-names>Qingjiong</given-names></name></contrib><aff id="aff1">State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China</aff></contrib-group><author-notes><fn><p>Dr. Wang and Dr. Yang contributed equally to this work.</p></fn><corresp id="cor1">Correspondence to: Dr. Qingjiong Zhang, Ophthalmic Genetics and Molecular Biology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 Xianlie Road, Guangzhou, 510060, China; Phone: (+86)-20-87330422; FAX: (+86)-20-87333271; email: <email xlink:href="qingjiongzhang@yahoo.com">qingjiongzhang@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>23</day><month>1</month><year>2009</year></pub-date><volume>15</volume><fpage>181</fpage><lpage>186</lpage><history><date date-type="received"><day>26</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>18</day><month>1</month><year>2009</year></date></history><permissions><copyright-year>2009</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>Mutations in the membrane-type frizzled-related protein (<italic>MFRP</italic>) gene have been identified in patients with pathologic high hyperopia associated with nanophthalmos or microphthalmia. This study is to test if a mutation in <italic>MFRP</italic> is responsible for physiologic high hyperopia.</p></sec><sec sec-type="methods"><title>Methods</title><p>DNA was prepared from venous leukocytes of 51 patients with physiologic high hyperopia (refraction of spherical equivalent &#x02265;+5.00 [diopters] D) and 96 controls (refraction of spherical equivalent between &#x02212;0.50 D and +1.00 D). The coding regions and adjacent intronic sequence of <italic>MFRP</italic> were amplified by polymerase chain reaction (PCR) and were then analyzed by cycle sequencing. Variations detected were further evaluated in normal controls and available family members by heteroduplex- single-strand conformation polymorphism (SSCP) analysis or sequencing.</p></sec><sec><title>Results</title><p>The average spherical refractive error of patients was +8.41 D in the right eye (from +6.00 D to +16.5 D) and was +8.76 D in the left eye (from +6.00 D to +16.5 D). Five novel heterozygous variations in <italic>MFRP</italic>, c.55-14_55-13insGTAT, c.496C&#x0003e;G, c.664C&#x0003e;A, c.669G&#x0003e;A, and c.770G&#x0003e;A, were identified. Of these, c.664C&#x0003e;A (p.Pro222Thr) and c.669G&#x0003e;A (p.=) were not observed in the 96 normal controls. In addition, one known c.192C&#x0003e;G substitution and five single nucleotide polymorphisms (SNPs; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=883247">rs883247</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3814762">rs3814762</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=36015759">rs36015759</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2510143">rs2510143</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=35885438">rs35885438</ext-link>) were detected.</p></sec><sec><title>Conclusions</title><p>Several novel variations in <italic>MFRP</italic> were detected in Chinese. Our results imply that <italic>MFRP</italic> is less likely to play a major role in physiologic high hyperopia.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Hyperopia, alternatively termed hypermetropia or farsightedness, is a common refractive error in children and adults [<xref ref-type="bibr" rid="r1">1</xref>-<xref ref-type="bibr" rid="r3">3</xref>]. Hyperopia may be classified as low hyperopia (+2.00 diopters [D] or less), moderate hyperopia (between +2.25 D and +5.00 D), and high hyperopia (over +5.00 D) [<xref ref-type="bibr" rid="r4">4</xref>]. The prevalence of hyperopia (+3 D or higher) in adults is 9.9%, 11.6%, and 5.8% in the USA, Western European nations, and Australia, respectively [<xref ref-type="bibr" rid="r5">5</xref>]. Patients with high hyperopia may suffer from blurred vision, asthenopia, accommodative dysfunction, binocular dysfunction, amblyopia, strabismus, closure angle glaucoma, and retinal detachment. The morphological characteristics of high hyperopia include a short eye axis, a narrow angle between the cornea and iris, expansion of the choroidal vascular bed, and a thickening of sclera connective tissue [<xref ref-type="bibr" rid="r6">6</xref>]. Most cases of high hyperopia are physiologic high hyperopia that is not associated with other ocular or systemic anomalies. However, pathologic high hyperopia may present as a part of other eye abnormalities such as nanophthalmos, microphthalmia, anterior segment malformations, and Leber congenital amaurosis [<xref ref-type="bibr" rid="r7">7</xref>-<xref ref-type="bibr" rid="r9">9</xref>] while there are also numbers of high hyperopia associated with systemic syndromes such as Down syndrome and fragile X syndrome [<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r11">11</xref>]. Compared with myopia, hereditary factors may play a more important role than environmental factors in the development of high hyperopia [<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r13">13</xref>]. Mutations in <italic>MFRP</italic> have been identified to be responsible for nanophthalmos 2 (NNO2, OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=609549">609549</ext-link>) and microphthalmia (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=611040">611040</ext-link>), where extremely high hyperopia (+8.00 D-+25.00 D) is a prominent sign [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r8">8</xref>,<xref ref-type="bibr" rid="r14">14</xref>]. However, whether variations in <italic>MFRP</italic> play any role in physiologic high hyperopia is still unclear, although <italic>MFRP</italic> in 11 individuals with hyperopia (4 of the 11 with high hyperopia) has been analyzed [<xref ref-type="bibr" rid="r14">14</xref>].</p><p>The membrane-type frizzled related protein gene (<italic>MFRP</italic>; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=606227">606227</ext-link>), located in 11q23, is comprised of 13 exons, which translate into a 579 amino acid protein. Selectively expressed in the retinal pigment epithelium and the ciliary body with C1q and tumor necrosis factor related protein 5 (CTRP5) [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r15">15</xref>], the protein contains three domains, a cysteine-rich domain (CRD) at the COOH-terminus, a type II transmembrane domain, and an extracellular region with two tandem-repeats of cubilin (CUB) at the NH<sub>2</sub>-terminus [<xref ref-type="bibr" rid="r16">16</xref>]. The CRD can bind with Wnts (wingless type proteins), which belong to a family of cell signaling molecules that are possibly involved in eye development through mediating cell growth [<xref ref-type="bibr" rid="r17">17</xref>]. Additionally, CUB is homologous with the low density lipoprotein (LDL) receptor. Normal function of <italic>MFRP</italic> is essential for the eye to reach its full size at birth and is necessary for emmetropization, which is associated with the regulation of ocular axial growth [<xref ref-type="bibr" rid="r18">18</xref>]. Although a splice mutation of <italic>Mfrp</italic> causes a recessive retinal degeneration in the rd6 mouse [<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r20">20</xref>], recessive mutations of <italic>MFRP</italic> have been detected in humans with nanophthalmos [<xref ref-type="bibr" rid="r8">8</xref>] and have been reported to be associated with an autosomal recessive ophthalmic syndrome characterized by posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r22">22</xref>]. Since the simple hyperopia cases represent a less severe form of a short axial length that is similar to the delineation of nanophthalmos [<xref ref-type="bibr" rid="r18">18</xref>], <italic>MFRP</italic> may also be the etiological factor of simple high hyperopia. The identification of the causative or susceptibility genetic factors involved in simple high hyperopia will have clinical implications for both ophthalmology and optometry.</p><p>Here, <italic>MFRP</italic> was analyzed in 51 Chinese patients with physiologic high hyperopia to determine whether <italic>MFRP</italic> plays a role in the development of high hyperopia.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patients and clinical data</title><p>A previously established and published procedure was used for collecting subjects and obtaining informed consent [<xref ref-type="bibr" rid="r23">23</xref>]. This study followed the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of Zhongshan Ophthalmic Center (Guangzhou, China). Chinese subjects with high hyperopia who met the following criteria were recruited: 1) they had bilateral refraction errors of +5.00 D or higher (spherical equivalent) and 2) they had no other known ocular or systemic diseases. A group of 96 controls met the following criteria: 1) bilateral refraction between &#x02013;0.50 D and +1.00 D and 2) no family history of hyperopia. The refractive error for all eyes was measured with cycloplegic autorefraction after mydriasis (Mydrin&#x000ae;-P, a compound tropicamide; Santen Pharmaceutical Co. Ltd., Osaka, Japan). Ophthalmologic examinations were performed by ophthalmologists (Z.Y., Q.Z., and X.G.). Genomic DNA was prepared from the venous blood of 51 unrelated patients with high hyperopia and of the 96 normal controls.</p></sec><sec><title>Variation analysis</title><p>Eight pairs of primers were used to amplify the 13 coding exons and the adjacent intronic sequence of <italic>MFRP</italic> (human genome build 36.2 <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=51511727">NC_000011.8</ext-link> for gDNA, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_031433.1">NM_031433.1</ext-link> for cDNA, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=protein&#x00026;id=13899255">NP_113621.1</ext-link> for protein; <xref ref-type="table" rid="t1">Table 1</xref>). The polymerase chain reaction (PCR) products for the individual exons from each patient were sequenced with the ABI BigDye Terminator cycle sequencing kit version 3.1 (Applied Biosystems, Foster City, CA) according to the manufacturer's recommendations using an ABI 3100 Genetic Analyzer (Applied Biosystems). Sequencing results from the patients as well as <italic>MFRP</italic> consensus sequences from the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">NCBI</ext-link> human genome database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&#x00026;id=13899254">NM_031433.1</ext-link>) were imported into the SeqManII program of the Lasergene package (DNASTAR Inc., Madison, Wisconsin) and aligned to identify variations. Each variation was confirmed by bidirectional sequencing. The nomenclature of the variation was performed according to the directions recommended by the <ext-link ext-link-type="uri" xlink:href="http://www.hgvs.org">Human Genomic Variation Society</ext-link>. Any detected novel variation in <italic>MFRP</italic> was further evaluated by either heteroduplex-SSCP (single-strand conformation polymorphism) analysis [<xref ref-type="bibr" rid="r24">24</xref>] or by direct sequencing in available family members as well as in the 96 normal controls. Extra pairs of primers were designed for heteroduplex-SSCP analysis (<xref ref-type="table" rid="t2">Table 2</xref>). Five variations (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=36015759">rs36015759</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2510143">rs2510143</ext-link>, c.55-14_55-13insGTAT, c.496C&#x0003e;G, and c.770G&#x0003e;A) were genotyped and tested for association using Fisher&#x02019;s exact test with a significance level threshold of 0.05.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Primers used for polymerase chain reaction amplification and sequencing of <italic>MFRP</italic>.</title></caption><table frame="hsides" rules="groups"><col width="40" span="1"/><col width="197" span="1"/><col width="83" span="1"/><col width="108" span="1"/><col width="64" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Exon</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Primer sequence (5'-3')</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Size of PCR product (bp)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Annealing temperature (&#x000b0;C)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Note</bold></th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">1,2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F-CTTTTCCCTCGGGTAGTAGA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">466<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GC buffer<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-GTTGGCAGGTGGGGTTTTGAA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">3,4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F-AGGACAGCATGAGGAATACC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">504<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">62<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-AACCCCACCCCGTCATCTTG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F-GAGAAGGGCCCAAGATGACG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">405<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">63<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GC buffer<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-TCCCTGCCACTCCCTGATTC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">6,7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F-TTGGGGGTTGAGAAAATAGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">601<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-CTGGGCCAAAGAATGACTGA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">8<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F-ATCACCGCCAGCCCTATTG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">281<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">62<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-CATCCCCCGTCTGCTTGAT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">9<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F-GGTGCCCGGGATGAGACAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">267<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">62<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GC buffer<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-CCGGGGGTGGCAGACAGT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">10,11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F-GCAGTGCCCCCTCAGTCAGC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">511<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">64<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-GTGGGCACCCAGCCTGCTC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">12,13</td><td valign="top" align="left" rowspan="1" colspan="1">F-CAGGCCACAGAGCCAGTGAG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">548<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">63<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-AGCCCTGACCGGCAAAAGAG</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>GC buffer was provided by Takara Biotechnology (Dalian) CO.Ltd (Liaoning,China) and designed for amplification of templates having complex secondary structure or high GC content. In the "Primer sequence" column, "F" indicates the forward sequence and "R" indicates the reverse sequence.</p></table-wrap-foot></table-wrap><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Primers used for evaluating the variations by heteroduplex-single strand conformational polymorphism analysis.</title></caption><table frame="hsides" rules="groups"><col width="86" span="1"/><col width="215" span="1"/><col width="81" span="1"/><col width="63" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Variations</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Primer sequence (5'-3')</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Size of PCR product (bp)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Annealing temp (&#x000b0;C)</bold></th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">c.192C&#x0003e;G<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F-TGCCCTCAGCCCTCAAGTATC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">340<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">66<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-CAGCCCAAGCAGCAGGAGGAG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">c.55-14_55-13insGTAT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F-CTTTTCCCTCGGGTAGTAGA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">344<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">62<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-GACGCTGTAGCTGGCATCCT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">c.664C&#x0003e;A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F-TCTCTGGCTGACCCTGCTCTT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">152<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">c.669G&#x0003e;A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R-AAACCAAATCCTTCCACACTGCT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td rowspan="2" valign="top" align="center" scope="row" colspan="1">c.770G&#x0003e;A</td><td valign="top" align="left" rowspan="1" colspan="1">F-TTGGGGGTTGAGAAAATAGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">283<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60<hr/></td></tr><tr><td valign="top" colspan="1" align="left" scope="col" rowspan="1">R-TGGGTGGAGGGGAAGAAAGTG</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><p>In the "Primer sequence" column, "F" indicates the forward sequence and "R" indicates the reverse sequence.</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="results"><title>Results</title><p>A total of 51 unrelated patients with high hyperopia were recruited into our study. The average spherical refractive error of patients was +8.41 diopters in the right eye (from +6.00 D to +16.5 D) and was +8.76D in left eye (form +6.00D to +16.5 D). Direct sequencing identified 11 heterozygous variations in <italic>MFRP</italic> where the following five variations were novel: c.55-14_55-13insGTAT, c.496C&#x0003e;G, c.664C&#x0003e;A, c.669G&#x0003e;A, and c.770G&#x0003e;A (<xref ref-type="table" rid="t3">Table 3</xref> and <xref ref-type="fig" rid="f1">Figure 1A</xref>). Except for c.664C&#x0003e;A and c.669G&#x0003e;A, the rest of the novel variations were observed in the normal controls by heteroduplex-SSCP analysis (<xref ref-type="fig" rid="f1">Figure 1B</xref>). For the missense variation, c.664C&#x0003e;A (p.Pro222Thr), which was identified in one patient, the threonine (a small, hydrophobic amino acid carrying charge) took the place of proline (a small amino acid), which resulted in a change at the protein level with a residue weight of &#x02212;1 (evaluated by amino acid substitution matrices Blosum 62). The proline at position 222 is highly conserved for MFRP as demonstrated by an analysis of six orthologs from different vertebrate species (<xref ref-type="fig" rid="f1">Figure 1C</xref>). For the synonymous variation, c.669G&#x0003e;A, observed in two patients, the substitution did not change the amino acid or transcript splicing. In addition, a reported substitution, c.192C&#x0003e;G [<xref ref-type="bibr" rid="r25">25</xref>], and five SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=883247">rs883247</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3814762">rs3814762</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=36015759">rs36015759</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2510143">rs2510143</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=35885438">rs35885438</ext-link>) were observed. No statistical association was observed for variations (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=36015759">rs36015759</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2510143">rs2510143</ext-link>, c.55-14_55-13insGTAT, c.496C&#x0003e;G, and c.770G&#x0003e;A) between high hyperopes and controls.</p><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Sequence variations in <italic>MFRP</italic> observed in 51 patients with hyperopia.</title></caption><table frame="hsides" rules="groups"><col width="144" span="1"/><col width="57" span="1"/><col width="74" span="1"/><col width="70" span="1"/><col width="68" span="1"/><col width="93" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Variations</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Location</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Change</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Effect</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Hyperopia (n=51)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Normal control (n=96)</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">c.1&#x02013;31G&#x0003e;A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5&#x02032;<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GGA-GAA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=883247">rs883247</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">26<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">ND<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><bold>c.55-14_55-13insGTAT</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Intron 1</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>insertGTAT</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>No effect</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>3</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>7*</bold><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">c.192C&#x0003e;G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Exon 3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CGC-CGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Arg-Arg<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">c.406G&#x0003e;A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Exon 4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">GTG-ATG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3814762">rs3814762</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">ND<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">c.492C&#x0003e;T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Exon 5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">TAC-TAT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=36015759">rs36015759</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">36*<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><bold>c.496C&#x0003e;G</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Exon 5</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>CCC-GCC</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Pro-Ala</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>1</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>3*</bold><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">c.540T&#x0003e;C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Exon 5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CAT-CAC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2510143">rs2510143</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">51<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95*<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><bold>c.664C&#x0003e;A</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Exon 6</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>CCC-ACC</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Pro-Thr</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>1</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><bold>c.669G&#x0003e;A</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Exon 6</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>ACG-ACA</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Thr-Thr</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>2</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>0</bold><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><bold>c.770G&#x0003e;A</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Exon 6</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>CGC-CAC</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>Arg-His</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>1</bold><hr/></td><td valign="top" align="center" rowspan="1" colspan="1"><bold>2*</bold><hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">c.954G&#x0003e;A</td><td valign="top" align="center" rowspan="1" colspan="1">Exon 8</td><td valign="top" align="center" rowspan="1" colspan="1">CTG-CTA</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=35885438">rs35885438</ext-link></td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">ND</td></tr></tbody></table><table-wrap-foot><p>The novel variations are highlighted in bold. An asterisk indicates that no statistical difference was observed between patients and controls. ND: no detected.</p></table-wrap-foot></table-wrap><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>The five novel variations identified in <italic>MFRP</italic>. <bold>A</bold>: The sequences of variations (indicated by an arrow) are shown on the left to compare with the wild type sequences on the right. <bold>B</bold>: The variations, c.664C&#x0003e;A and c.669G&#x0003e;A, were not observed in normal controls (NC) by heteroduplex-SSCP analysis. <bold>C</bold>: The mutation, c.664C&#x0003e;A (indicated by an arrow), changed a highly conserved residue from proline to threonine.</p></caption><graphic xlink:href="mv-v15-181-f1"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>Recently, <italic>MFRP</italic> was evaluated among 11 hyperopia patients. Five novel variations were identified, but direct sequencing and family-based association analysis of these variations did not implicate <italic>MFRP</italic> in the process of moderate to high hyperopia [<xref ref-type="bibr" rid="r14">14</xref>]. We screened this gene in a larger cohort of physiologic high hyperopia and identified five novel sequence variations of <italic>MFRP</italic> from 51 patients. Three of these (c.55-14_55-13insGTAT, c.496C&#x0003e;G, and c.770G&#x0003e;A) appeared to be common <italic>MFRP</italic> polymorphisms because all of them were screened not only in patients but also in normal controls. Two variations, c.664C&#x0003e;A (missense) and c.669G&#x0003e;A (silent), were detected in only patients with high hyperopia.</p><p><italic>MFRP</italic> has already been screened in patients with different kinds of inherited eye diseases such as nanophthalmos 2 (NNO2, OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=609549">609549</ext-link>) [<xref ref-type="bibr" rid="r26">26</xref>], posterior microphthalmia with retinitis pigmentosa, foveoschisis and optic disc drusen (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=611040">611040</ext-link>) [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r22">22</xref>], retinopathy [<xref ref-type="bibr" rid="r27">27</xref>], glaucoma [<xref ref-type="bibr" rid="r25">25</xref>,<xref ref-type="bibr" rid="r28">28</xref>], and ocular disease related to axial length [<xref ref-type="bibr" rid="r14">14</xref>]. Besides six MFRP mutations identified in patients with NNO2 or posterior microphthalmia with retinal degeneration, many non-pathological variations were observed in <italic>MFRP</italic>. Among the six causative <italic>MFRP</italic> mutations, four of them were homozygous (c.498insC, c.498delC, c.524T&#x0003e;C, and c.1143insC), and two of them were compound heterozygous (c.492delC and c.545C&#x0003e;T). Five of the mutations were located in exon 5 (428&#x02013;641 bp of the consensus coding sequence), which led to an assumption that the tract of short peptide in this region might play a role in the etiology of eye anomalies [<xref ref-type="bibr" rid="r21">21</xref>]. We identified a heterozygous missense variation, c.496C&#x0003e;G (p.Pro166Ala), but this variation was also observed in normal controls and the clinically normal mother of the patient with the variation. Although it is less possible for the c.496C&#x0003e;G variation of <italic>MFRP</italic> to account for hyperopia, the recognition of this missense variation in the short tract of exon 5 in <italic>MFRP</italic> will help further the understanding of the role of this area in the function of MFRP.</p><p>A silent variation (c.669G&#x0003e;A) presented in <italic>MFRP</italic> of two patients with high hyperopia, but none of the controls carried this change. Although the substitution did not change the encoded amino acid or splice method, it might affect the in vivo stability of the mRNA or protein folding, which is what has been observed for other silent variations in other systems [<xref ref-type="bibr" rid="r29">29</xref>-<xref ref-type="bibr" rid="r31">31</xref>]. Therefore, it is a variation in <italic>MFRP</italic> that has the potential to cause hyperopia. The missense variation, c.664C&#x0003e;A, resulted in a significant change at the amino acid level as evaluated by Blosum 62 (&#x02212;1), and this substitution was not identified in the normal controls. Unfortunately, no other family members of this patient were available for us to perform a cosegregation analysis on this variation. More research is needed to reveal the effect of the two <italic>MFRP</italic> variations on simple high hyperopia.</p><p>In conclusion, five novel sequence variations of <italic>MFRP</italic> were identified in the Chinese population where two of these novel variations were only present in patients with physiologic high hyperopia. Our results imply that <italic>MFRP</italic> is not likely to play a major role in physiologic high hyperopia. Further studies are needed to clarify this point.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank all patients and controls for their participation. This study was supported in part by the National 863 Plan of China (Z19&#x02013;01&#x02013;04&#x02013;02 to Q.Z.) and the National Science Fund for Distinguished Young Scholars (30725044 to Q.Z.).</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>KJ</given-names></name><name><surname>Woodhouse</surname><given-names>JM</given-names></name><name><surname>Westall</surname><given-names>CA</given-names></name></person-group><article-title>Emmetropisation in human infancy: rate of change is related to initial refractive error.</article-title><source>Vision Res</source><year>1995</year><volume>35</volume><fpage>1325</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7610593</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="book">Hirsch MJ, Weymouth FW. Prevalence of refractive anomalies. In: Grosvenor T, Flom M, editors. Refractive anomalies: Research and clinical applications. Boston: Butterworth-Heinemann; 1991. p. 15&#x02013;38.</citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>MW</given-names></name></person-group><article-title>Changes in refraction over a period of twenty years in a non-visually selected sample.</article-title><source>Am J Optom Arch Am Acad Optom</source><year>1958</year><volume>35</volume><fpage>281</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">13545339</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="book">Augsburger A. Hyperopia. In: Amos JF, editor. Diagnosis and management in vision care. Boston: Butterworths; 1987. p. 101&#x02013;19.</citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kempen</surname><given-names>JH</given-names></name><name><surname>Mitchell</surname><given-names>P</given-names></name><name><surname>Lee</surname><given-names>KE</given-names></name><name><surname>Tielsch</surname><given-names>JM</given-names></name><name><surname>Broman</surname><given-names>AT</given-names></name><name><surname>Taylor</surname><given-names>HR</given-names></name><name><surname>Ikram</surname><given-names>MK</given-names></name><name><surname>Congdon</surname><given-names>NG</given-names></name><name><surname>O'Colmain</surname><given-names>BJ</given-names></name><collab>Eye Diseases Prevalence Research Group</collab></person-group><article-title>The prevalence of refractive errors among adults in the United States, Western Europe, and Australia.</article-title><source>Arch Ophthalmol</source><year>2004</year><volume>122</volume><fpage>495</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">15078666</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sundin</surname><given-names>OH</given-names></name><name><surname>Leppert</surname><given-names>GS</given-names></name><name><surname>Silva</surname><given-names>ED</given-names></name><name><surname>Yang</surname><given-names>JM</given-names></name><name><surname>Dharmaraj</surname><given-names>S</given-names></name><name><surname>Maumenee</surname><given-names>IH</given-names></name><name><surname>Santos</surname><given-names>LC</given-names></name><name><surname>Parsa</surname><given-names>CF</given-names></name><name><surname>Traboulsi</surname><given-names>EI</given-names></name><name><surname>Broman</surname><given-names>KW</given-names></name><name><surname>Dibernardo</surname><given-names>C</given-names></name><name><surname>Sunness</surname><given-names>JS</given-names></name><name><surname>Toy</surname><given-names>J</given-names></name><name><surname>Weinberg</surname><given-names>EM</given-names></name></person-group><article-title>Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein.</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>9553</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15976030</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waring</surname><given-names>GO</given-names><suffix>3rd</suffix></name><name><surname>Rodrigues</surname><given-names>MM</given-names></name><name><surname>Laibson</surname><given-names>PR</given-names></name></person-group><article-title>Anterior chamber cleavage syndrome. A stepladder classification.</article-title><source>Surv Ophthalmol</source><year>1975</year><volume>20</volume><fpage>3</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">808872</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Othman</surname><given-names>MI</given-names></name><name><surname>Sullivan</surname><given-names>SA</given-names></name><name><surname>Skuta</surname><given-names>GL</given-names></name><name><surname>Cockrell</surname><given-names>DA</given-names></name><name><surname>Stringham</surname><given-names>HM</given-names></name><name><surname>Downs</surname><given-names>CA</given-names></name><name><surname>Fornes</surname><given-names>A</given-names></name><name><surname>Mick</surname><given-names>A</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Vollrath</surname><given-names>D</given-names></name><name><surname>Richards</surname><given-names>JE</given-names></name></person-group><article-title>Autosomal dominant nanophthalmos (NNO1) with high hyperopia and angle-closure glaucoma maps to chromosome 11.</article-title><source>Am J Hum Genet</source><year>1998</year><volume>63</volume><fpage>1411</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9792868</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foxman</surname><given-names>SG</given-names></name><name><surname>Heckenlively</surname><given-names>JR</given-names></name><name><surname>Bateman</surname><given-names>JB</given-names></name><name><surname>Wirtschafter</surname><given-names>JD</given-names></name></person-group><article-title>Classification of congenital and early onset retinitis pigmentosa.</article-title><source>Arch Ophthalmol</source><year>1985</year><volume>103</volume><fpage>1502</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">4051853</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maino</surname><given-names>DM</given-names></name><name><surname>Schlange</surname><given-names>D</given-names></name><name><surname>Maino</surname><given-names>JH</given-names></name><name><surname>Caden</surname><given-names>B</given-names></name></person-group><article-title>Ocular anomalies in fragile X syndrome.</article-title><source>J Am Optom Assoc</source><year>1990</year><volume>61</volume><fpage>316</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">2189924</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Catalano</surname><given-names>RA</given-names></name></person-group><article-title>Down syndrome.</article-title><source>Surv Ophthalmol</source><year>1990</year><volume>34</volume><fpage>385</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">2139246</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mutti</surname><given-names>DO</given-names></name><name><surname>Zadnik</surname><given-names>K</given-names></name><name><surname>Adams</surname><given-names>AJ</given-names></name></person-group><article-title>Myopia. The nature versus nurture debate goes on.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1996</year><volume>37</volume><fpage>952</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8631638</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>J</given-names></name><name><surname>Holm</surname><given-names>K</given-names></name><name><surname>Vilhelmsen</surname><given-names>K</given-names></name><name><surname>Rosenberg</surname><given-names>T</given-names></name><name><surname>Scherfig</surname><given-names>E</given-names></name><name><surname>Fledelius</surname><given-names>HC</given-names></name></person-group><article-title>Hereditary high hypermetropia in the Faroe Islands.</article-title><source>Ophthalmic Genet</source><year>2005</year><volume>26</volume><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">15823920</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metlapally</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>YJ</given-names></name><name><surname>Tran-Viet</surname><given-names>KN</given-names></name><name><surname>Bulusu</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>TR</given-names></name><name><surname>Ellis</surname><given-names>J</given-names></name><name><surname>Kao</surname><given-names>D</given-names></name><name><surname>Young</surname><given-names>TL</given-names></name></person-group><article-title>Common MFRP sequence variants are not associated with moderate to high hyperopia, isolated microphthalmia, and high myopia.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>387</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">18334955</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayyagari</surname><given-names>R</given-names></name><name><surname>Mandal</surname><given-names>MN</given-names></name><name><surname>Karoukis</surname><given-names>AJ</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>McLaren</surname><given-names>NC</given-names></name><name><surname>Lichter</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>DT</given-names></name><name><surname>Hitchcock</surname><given-names>PF</given-names></name><name><surname>Caruso</surname><given-names>RC</given-names></name><name><surname>Moroi</surname><given-names>SE</given-names></name><name><surname>Maumenee</surname><given-names>IH</given-names></name><name><surname>Sieving</surname><given-names>PA</given-names></name></person-group><article-title>Late-onset macular degeneration and long anterior lens zonules result from a CTRP5 gene mutation.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2005</year><volume>46</volume><fpage>3363</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">16123441</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname><given-names>M</given-names></name></person-group><article-title>Molecular cloning and characterization of MFRP, a novel gene encoding a membrane-type Frizzled-related protein.</article-title><source>Biochem Biophys Res Commun</source><year>2001</year><volume>282</volume><fpage>116</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">11263980</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Iongh</surname><given-names>RU</given-names></name><name><surname>Abud</surname><given-names>HE</given-names></name><name><surname>Hime</surname><given-names>GR</given-names></name></person-group><article-title>WNT/Frizzled signaling in eye development and disease.</article-title><source>Front Biosci</source><year>2006</year><volume>11</volume><fpage>2442</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">16720326</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sundin</surname><given-names>OH</given-names></name><name><surname>Dharmaraj</surname><given-names>S</given-names></name><name><surname>Bhutto</surname><given-names>IA</given-names></name><name><surname>Hasegawa</surname><given-names>T</given-names></name><name><surname>McLeod</surname><given-names>DS</given-names></name><name><surname>Merges</surname><given-names>CA</given-names></name><name><surname>Silval</surname><given-names>ED</given-names></name><name><surname>Maumenee</surname><given-names>IH</given-names></name><name><surname>Lutty</surname><given-names>GA</given-names></name></person-group><article-title>Developmental basis of nanophthalmos: MFRP Is required for both prenatal ocular growth and postnatal emmetropization.</article-title><source>Ophthalmic Genet</source><year>2008</year><volume>29</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18363166</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kameya</surname><given-names>S</given-names></name><name><surname>Hawes</surname><given-names>NL</given-names></name><name><surname>Chang</surname><given-names>B</given-names></name><name><surname>Heckenlively</surname><given-names>JR</given-names></name><name><surname>Naggert</surname><given-names>JK</given-names></name><name><surname>Nishina</surname><given-names>PM</given-names></name></person-group><article-title>Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6.</article-title><source>Hum Mol Genet</source><year>2002</year><volume>11</volume><fpage>1879</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">12140190</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Simon</surname><given-names>A</given-names></name><name><surname>Eriksson</surname><given-names>U</given-names></name><name><surname>Harris</surname><given-names>E</given-names></name><name><surname>Berson</surname><given-names>EL</given-names></name><name><surname>Dryja</surname><given-names>TP</given-names></name></person-group><article-title>Mutations in the gene encoding 11-cis retinol dehydrogenase cause delayed dark adaptation and fundus albipunctatus.</article-title><source>Nat Genet</source><year>1999</year><volume>22</volume><fpage>188</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">10369264</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crespi</surname><given-names>J</given-names></name><name><surname>Buil</surname><given-names>JA</given-names></name><name><surname>Bassaganyas</surname><given-names>F</given-names></name><name><surname>Vela-Segarra</surname><given-names>JI</given-names></name><name><surname>Diaz-Cascajosa</surname><given-names>J</given-names></name><name><surname>Ayala-Ramirez</surname><given-names>R</given-names></name><name><surname>Zenteno</surname><given-names>JC</given-names></name></person-group><article-title>A Novel Mutation Confirms MFRP as the Gene Causing the Syndrome of Nanophthalmos-Renititis Pigmentosa-Foveoschisis-Optic Disk Drusen.</article-title><source>Am J Ophthalmol</source><year>2008</year><volume>146</volume><fpage>323</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18554571</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ayala-Ramirez</surname><given-names>R</given-names></name><name><surname>Graue-Wiechers</surname><given-names>F</given-names></name><name><surname>Robredo</surname><given-names>V</given-names></name><name><surname>Amato-Almanza</surname><given-names>M</given-names></name><name><surname>Horta-Diez</surname><given-names>I</given-names></name><name><surname>Zenteno</surname><given-names>JC</given-names></name></person-group><article-title>A new autosomal recessive syndrome consisting of posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen is caused by a MFRP gene mutation.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>1483</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17167404</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Jia</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name></person-group><article-title>The 208delG mutation in FSCN2 does not associate with retinal degeneration in Chinese individuals.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>530</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">17251446</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Minoda</surname><given-names>K</given-names></name></person-group><article-title>Detection of congenital color vision defects using heteroduplex-SSCP analysis.</article-title><source>Jpn J Ophthalmol</source><year>1996</year><volume>40</volume><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">8739504</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aung</surname><given-names>T</given-names></name><name><surname>Lim</surname><given-names>MC</given-names></name><name><surname>Wong</surname><given-names>TT</given-names></name><name><surname>Thalamuthu</surname><given-names>A</given-names></name><name><surname>Yong</surname><given-names>VH</given-names></name><name><surname>Venkataraman</surname><given-names>D</given-names></name><name><surname>Venkatraman</surname><given-names>A</given-names></name><name><surname>Chew</surname><given-names>PT</given-names></name><name><surname>Vithana</surname><given-names>EN</given-names></name></person-group><article-title>Molecular analysis of CHX10 and MFRP in Chinese subjects with primary angle closure glaucoma and short axial length eyes.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1313</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18648522</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sundin</surname><given-names>OH</given-names></name></person-group><article-title>The mouse's eye and Mfrp: not quite human.</article-title><source>Ophthalmic Genet</source><year>2005</year><volume>26</volume><fpage>153</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16352474</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pauer</surname><given-names>GJ</given-names></name><name><surname>Xi</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Traboulsi</surname><given-names>EI</given-names></name><name><surname>Hagstrom</surname><given-names>SA</given-names></name></person-group><article-title>Mutation screen of the membrane-type frizzled-related protein (MFRP) gene in patients with inherited retinal degenerations.</article-title><source>Ophthalmic Genet</source><year>2005</year><volume>26</volume><fpage>157</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">16352475</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>IJ</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Chiang</surname><given-names>TH</given-names></name><name><surname>Chen</surname><given-names>ZT</given-names></name><name><surname>Lin</surname><given-names>LL</given-names></name><name><surname>Hung</surname><given-names>PT</given-names></name><name><surname>Shih</surname><given-names>YF</given-names></name></person-group><article-title>The association of membrane frizzled-related protein (MFRP) gene with acute angle-closure glaucoma - a pilot study.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1673</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18781223</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimchi-Sarfaty</surname><given-names>C</given-names></name><name><surname>Oh</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>IW</given-names></name><name><surname>Sauna</surname><given-names>ZE</given-names></name><name><surname>Calcagno</surname><given-names>AM</given-names></name><name><surname>Ambudkar</surname><given-names>SV</given-names></name><name><surname>Gottesman</surname><given-names>MM</given-names></name></person-group><article-title>A &#x0201c;silent&#x0201d; polymorphism in the MDR1 gene changes substrate specificity.</article-title><source>Science</source><year>2007</year><volume>315</volume><fpage>525</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17185560</pub-id></citation></ref><ref id="r30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Komar</surname><given-names>AA</given-names></name></person-group><article-title>Genetics. SNPs, silent but not invisible.</article-title><source>Science</source><year>2007</year><volume>315</volume><fpage>466</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17185559</pub-id></citation></ref><ref id="r31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>M</given-names></name><name><surname>Mookherjee</surname><given-names>S</given-names></name><name><surname>Bhattacharjee</surname><given-names>A</given-names></name><name><surname>Thakur</surname><given-names>SK</given-names></name><name><surname>Bandyopadhyay</surname><given-names>AK</given-names></name><name><surname>Sen</surname><given-names>A</given-names></name><name><surname>Chakrabarti</surname><given-names>S</given-names></name><name><surname>Ray</surname><given-names>K</given-names></name></person-group><article-title>Evaluation of the OPTC gene in primary open angle glaucoma: functional significance of a silent change.</article-title><source>BMC Mol Biol</source><year>2007</year><volume>8</volume><fpage>21</fpage><pub-id pub-id-type="pmid">17359525</pub-id></citation></ref></ref-list></back></article> 